屈玲玲 朱麗 黃玲玲 徐有祖
[摘要] 目的 探討心理-運(yùn)動(dòng)-睡眠三聯(lián)康復(fù)干預(yù)對(duì)肺癌化療患者心理狀態(tài)、睡眠質(zhì)量及癌因性疲乏的改善作用。方法 選取2017年1月~2018年12月呼吸內(nèi)科門診治療的肺癌化療后患者80例,隨機(jī)將研究對(duì)象分為干預(yù)組和對(duì)照組,各40例。對(duì)照組患者予常規(guī)干預(yù)措施。干預(yù)組患者在對(duì)照組基礎(chǔ)上予以心理-運(yùn)動(dòng)-睡眠三聯(lián)康復(fù)干預(yù)。兩組患者均干預(yù)8周。觀察并比較兩組患者干預(yù)前與干預(yù)8周后心理狀態(tài)、睡眠質(zhì)量及癌因性疲乏指標(biāo)的改善情況。 結(jié)果 干預(yù)8周后,兩組患者SAS評(píng)分和SDS評(píng)分均較前不同程度下降(P<0.05或P<0.01),且干預(yù)組患者下降幅度與對(duì)照組比較更顯著(P<0.05);兩組PSQI評(píng)分和PFS-R評(píng)分均較前不同程度下降(P<0.05或P<0.01),且干預(yù)組患者下降幅度與對(duì)照組比較更顯著(P<0.05)。 結(jié)論 心理-運(yùn)動(dòng)-睡眠三聯(lián)康復(fù)干預(yù)用于肺癌化療患者不僅可降低其抑郁及焦慮評(píng)分,改善其心理狀態(tài),而且改善其睡眠質(zhì)量,緩解其癌性疲乏癥狀。
[關(guān)鍵詞] 肺癌;化療;心理-運(yùn)動(dòng)-睡眠三聯(lián)康復(fù)干預(yù);心理狀態(tài);睡眠質(zhì)量;癌因性疲乏
[中圖分類號(hào)] R473.73? ? ? ? ? [文獻(xiàn)標(biāo)識(shí)碼] B? ? ? ? ? [文章編號(hào)] 1673-9701(2020)05-0087-04
Improvement effect of psychology-sports-sleep triple rehabilitation intervention on psychological status, sleep quality and cancer-induced fatigue in the patients undergoing lung cancer chemotherapy
QU Lingling1 ZHU Li1 HUANG Lingling2 XU Youzu1
1.Department of Respiratory Medicine, Taizhou Hospital of Zhejiang Province,Linhai? ?317000,China;2.Department of Hepatobiliary Surgery,Taizhou Hospital of Zhejiang Province,Linhai? ?317000,China
[Abstract] Objective To explore the improvement effect of psychology-sports-sleep triple rehabilitation intervention on the psychological status,sleep quality and cancer-induced fatigue in the patients undergoing lung cancer chemotherapy. Methods 80 patients with lung cancer after chemotherapy who were treated in the outpatient department of respiratory medicine from January 2017 to December 2018 were selected.The subjects were randomly divided into intervention group and control group,with 40 cases in each group. Patients in the control group were given routine intervention measures. Patients in the intervention group were given psychology-sports-sleep triple rehabilitation intervention on the basis of the control group. Both groups of patients were given intervention for 8 weeks. The improvements of psychological status,sleep quality and cancer-induced fatigue index before intervention and 8 weeks after intervention were observed and compared between the two groups. Results After 8 weeks of intervention,the SAS score and SDS score of the two groups of patients were lower at different degrees than those before(P<0.05 or P<0.01),and the decrease in the intervention group was more significant than that in the control group(P<0.05); the PSQI score and PFS-R score in the two groups were lower at different degrees than those before(P<0.05 or P<0.01),and the decrease in the intervention group was more significant than that in the control group(P<0.05). Conclusion Psychology-sports-sleep triple rehabilitation intervention for patients undergoing lung cancer chemotherapy can not only reduce their depression and anxiety scores,but also improve their psychological status,improves the quality of sleep and relieves symptoms of cancer-induced fatigue.
[Key words] Lung cancer; Chemotherapy; Psychology-sports-sleep triple rehabilitation intervention; Psychological status; Sleep quality; Cancer-induced fatigue
肺癌是一種我國(guó)常見(jiàn)的肺部惡性腫瘤,近年來(lái)其發(fā)生率和死亡率逐年增長(zhǎng),且有年輕化趨勢(shì)[1]?;熓悄壳爸委煼伟┑某S幂o助手段,化療期間易出現(xiàn)負(fù)性不良情緒、睡眠障礙及癌因性疲乏等不適癥狀,影響化療繼續(xù)進(jìn)行[2]。以往臨床上多采用心理安慰、認(rèn)知教育、藥物干預(yù)及飲食指導(dǎo)等方法治療肺癌化療后心理、睡眠障礙及癌因性疲乏等不適癥狀,但總體來(lái)說(shuō)效果欠理想[3,4]。心理-運(yùn)動(dòng)-睡眠干預(yù)是近年來(lái)興起的干預(yù)治療肺癌化療后心理、睡眠障礙及癌因性疲乏的措施,但單獨(dú)應(yīng)用部分患者效果欠理想,但三者聯(lián)合用于肺癌化療后患者目前臨床報(bào)道較少[5,6]。本研究分析了心理-運(yùn)動(dòng)-睡眠三聯(lián)康復(fù)干預(yù)改善肺癌化療患者心理狀態(tài)、睡眠質(zhì)量和癌因性疲乏作用,現(xiàn)報(bào)道如下。
1 資料與方法
1.1 一般資料
選擇2017年1月~2018年12月期間我院呼吸內(nèi)科門診就診的肺癌化療后患者80例。納入標(biāo)準(zhǔn)[7]:符合2010年制定的肺癌診斷標(biāo)準(zhǔn),并經(jīng)臨床、病理或細(xì)胞學(xué)檢查證實(shí),均采用TP化療方案[8]。排除標(biāo)準(zhǔn)[9]:(1)病情晚期惡液質(zhì)或嚴(yán)重營(yíng)養(yǎng)不良,預(yù)計(jì)生存時(shí)間<半年;(2)存在認(rèn)知、意識(shí)、智力及語(yǔ)言障礙者;(3)嚴(yán)重心腦、肝腎功能等重要臟器功能障礙者。隨機(jī)數(shù)字表將80例分為兩組各40例,兩組患者的一般資料比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05)。見(jiàn)表1。
1.2 治療方法
對(duì)照組患者予心理安慰、認(rèn)知教育、藥物干預(yù)及飲食指導(dǎo)等常規(guī)干預(yù)措施。
干預(yù)組患者在對(duì)照組基礎(chǔ)上予以心理-運(yùn)動(dòng)-睡眠三聯(lián)康復(fù)干預(yù),包括:(1)心理干預(yù):密切觀察患者心理情緒變化,耐心傾聽(tīng)患者訴求和感受,讓其發(fā)泄內(nèi)心的負(fù)面心理情緒,減輕患者焦慮、抑郁等情緒,減輕厭食情緒,幫助患者及家屬建立戰(zhàn)勝疾病的信心,從而用積極態(tài)度面對(duì)疾病,主動(dòng)配合治療;(2)運(yùn)動(dòng)干預(yù):結(jié)合患者體力狀態(tài)進(jìn)行中低強(qiáng)度有氧運(yùn)動(dòng)鍛煉,以室內(nèi)慢步行走為主,20~30 min/次,1~2次/d,運(yùn)動(dòng)后心率控制在目標(biāo)心率的50%~60%;(3)睡眠干預(yù):為患者創(chuàng)造良好的睡眠條件,根據(jù)制定的作息時(shí)間表及睡眠計(jì)劃表合理定時(shí)就寢,從而養(yǎng)成良好的作息及睡眠習(xí)慣,睡前應(yīng)嚴(yán)禁飲酒和咖啡飲料,盡量少食難消化食物。兩組患者均干預(yù)8周。觀察并比較兩組患者干預(yù)前與干預(yù)8周后心理狀態(tài)、睡眠質(zhì)量及癌因性疲乏指標(biāo)的改善情況。
1.3 觀察指標(biāo)
1.3.1 心理狀態(tài)評(píng)估[10]? 采用焦慮自評(píng)量表(SAS)和抑郁自評(píng)量表(SDS)評(píng)估患者的焦慮和抑郁癥狀。SAS和SDS均有20小項(xiàng),每項(xiàng)按癥狀輕重分為1~4分,20項(xiàng)分?jǐn)?shù)總和乘以1.25記為總分,SAS和SDS評(píng)分越高提示焦慮及抑郁心理狀態(tài)越明顯。
1.3.2 睡眠質(zhì)量評(píng)估[11]? 采用匹茲堡睡眠質(zhì)量指數(shù)量表(Pittsburgh sleep quality index,PSQI)評(píng)估睡眠情況,包括入睡時(shí)間、睡眠質(zhì)量、睡眠時(shí)間、催眠藥物、睡眠障礙、睡眠效率和日間功能障礙共7項(xiàng),每項(xiàng)按癥狀輕重分為1~3分,7項(xiàng)總分21分,PSQI評(píng)分越高提示睡眠質(zhì)量越糟糕。
1.3.3 癌因性疲乏癥狀評(píng)估? 采用1998年修訂的Piper疲乏修正量表(PFS-R)評(píng)估主觀疲乏感知程度[12],包括行為、軀體、情感和認(rèn)知四個(gè)維度,每項(xiàng)按癥狀評(píng)分為0~10分,PFS-R評(píng)分越高表示癌因性疲乏癥狀越重。
1.4 統(tǒng)計(jì)學(xué)處理
運(yùn)用SPSS18.0軟件進(jìn)行分析,計(jì)數(shù)資料進(jìn)行χ2檢驗(yàn),計(jì)量資料以均數(shù)±標(biāo)準(zhǔn)差(x±s)表示,采用t檢驗(yàn),P<0.05為差異有統(tǒng)計(jì)學(xué)意義。
2 結(jié)果
2.1 兩組SAS評(píng)分和SDS評(píng)分比較
干預(yù)前兩組SAS評(píng)分和SDS評(píng)分比較差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05)。干預(yù)8周后,兩組SAS評(píng)分和SDS評(píng)分均較前顯著下降(P<0.05或P<0.01),且干預(yù)組下降幅度與對(duì)照組比較更顯著(P<0.05)。見(jiàn)表2。
2.2 兩組PSQI評(píng)分和PFS-R評(píng)分比較
干預(yù)前兩組PSQI評(píng)分和PFS-R評(píng)分相差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05)。干預(yù)8周后,兩組PSQI評(píng)分和PFS-R評(píng)分均較前顯著下降(P<0.05或P<0.01),且干預(yù)組下降幅度與對(duì)照組比較更顯著(P<0.05)。見(jiàn)表3。
3 討論
近年來(lái)隨著人口老齡化、吸煙人群的增加及環(huán)境污染,肺癌的發(fā)病率及病死率在全球呈逐年上升的趨勢(shì)且年齡逐漸年輕化[13,14]?;熓悄壳爸委煼伟┑某S幂o助手段,但化療藥物在殺傷癌細(xì)胞的同時(shí),也對(duì)人體正常細(xì)胞也產(chǎn)生較強(qiáng)毒性作用,引起一系列毒副反應(yīng);而且在肺癌化療過(guò)程中,患者身體活動(dòng)狀況下調(diào),需消耗更多能量來(lái)維持其正?;顒?dòng)水平,加重患者的心理負(fù)擔(dān),易出現(xiàn)心理、睡眠障礙及癌因性疲乏,嚴(yán)重影響著患者的身心健康,導(dǎo)致患者生活質(zhì)量下降[15,16]。以往臨床上對(duì)肺癌化療后心理、睡眠障礙及癌因性疲乏等不適癥狀,常采用心理安慰、認(rèn)知教育、藥物干預(yù)及飲食指導(dǎo)等常規(guī)干預(yù)措施,雖然有一定的臨床療效,但這些干預(yù)措施主要側(cè)重于基本知識(shí)的認(rèn)知教育和相關(guān)的心理障礙、認(rèn)知缺乏、藥物用法及飲食問(wèn)題的干預(yù)解決,只能機(jī)械性參照以往書(shū)本的有關(guān)康復(fù)手段,并不能根據(jù)患者具體狀況及具體病情形成系統(tǒng)性康復(fù)方案,無(wú)法從根本上減輕及改善患者的臨床不適癥狀,因而總體效果欠佳[17,18]。
本研究將心理-運(yùn)動(dòng)-睡眠聯(lián)合康復(fù)干預(yù)用于肺癌化療患者,其中心理干預(yù)在于培養(yǎng)患者積極樂(lè)觀的人生態(tài)度,有效減輕悲觀、厭世、抑郁、焦慮等負(fù)性不良情緒,樹(shù)立起戰(zhàn)勝疾病的信心,減少對(duì)患者造成不良影響的各種環(huán)境刺激,鼓勵(lì)患者參與到治療方案制定和康復(fù)措施的實(shí)施中,實(shí)現(xiàn)自我心理的調(diào)節(jié),糾正不良心理情緒,改善心理狀況[19,20]。運(yùn)動(dòng)干預(yù)不僅可通過(guò)心理調(diào)節(jié)、神經(jīng)-內(nèi)分泌等途徑,加快人體新陳代謝速度,延緩患者因肌力水平下降導(dǎo)致全身酸脹痛、肢體僵硬和各種心理功能減退,并在保證組織及器官營(yíng)養(yǎng)供應(yīng)良好的情況下,加速人體體液循環(huán)的速度,減少人體新陳代謝的廢物堆積引起的不良影響,使得患者體力逐漸恢復(fù);還能明顯增強(qiáng)患者的心肺功能,改善生理狀態(tài),提高抗病能力,促進(jìn)健康,而且可刺激腦垂體分泌β-內(nèi)啡肽,作用中樞神經(jīng)系統(tǒng),產(chǎn)生良好的鎮(zhèn)靜作用,有效緩解或減輕心理緊張狀況,減輕抑郁、焦慮、緊張等不良心理情緒,促進(jìn)患者睡眠,減輕疲乏癥狀[21,22]。睡眠干預(yù)使患者養(yǎng)成良好的睡眠習(xí)慣,糾正機(jī)體的生物節(jié)律紊亂,使得患者白天的情緒及夜間睡眠質(zhì)量均達(dá)到良好狀態(tài),使得化療對(duì)患者的睡眠質(zhì)量造成的影響明顯減輕,促進(jìn)身心健康的恢復(fù),使患者對(duì)康復(fù)充滿信心;同時(shí)患者睡眠質(zhì)量的改善使患者保持平和的心境,減少患者焦慮、抑郁和緊張等負(fù)面不良情緒,起到良好的鎮(zhèn)靜和催眠作用,改善睡眠質(zhì)量,緩解其癌性疲乏癥狀[23-26]。本研究發(fā)現(xiàn)干預(yù)8周后,干預(yù)組SAS評(píng)分和SDS評(píng)分下降幅度與對(duì)照組比較更顯著,提示心理-運(yùn)動(dòng)-睡眠三聯(lián)康復(fù)干預(yù)用于肺癌化療患者可降低其抑郁及焦慮評(píng)分,改善其心理狀態(tài);同時(shí)研究干預(yù)組PSQI評(píng)分和PFS-R評(píng)分下降幅度亦與對(duì)照組比較更顯著,提示心理-運(yùn)動(dòng)-睡眠三聯(lián)康復(fù)干預(yù)用于肺癌化療患者可改善其睡眠質(zhì)量,緩解其癌性疲乏癥狀。
總之,心理-運(yùn)動(dòng)-睡眠三聯(lián)康復(fù)干預(yù)用于肺癌化療患者不僅可降低其抑郁及焦慮評(píng)分,改善其心理狀態(tài),而且改善其睡眠質(zhì)量,緩解其癌性疲乏癥狀。
[參考文獻(xiàn)]
[1] Calixto-Lima L,De Andrade EM,Gomes AP,et al. Dietetic management in gastrointestinal complications from antimalignant chemotherapy[J]. Nutr Hosp,2012,27(1):65-75.
[2] Jemal A,Bray F,Center MM,et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61(2):69-90.
[3] Imai H,Shukuya T,Yoshino R,et al.Efficacy and safety of platinum combination chemotherapy? re-challenge for relapsed patients with non-small-cell lung cancer after postoperative adjuvant chemotherapy of cisplatin plus vinorelbine[J]. Chemotherapy,2014,59(4):307-313.
[4] Kim JH,Van Beek EJ,Murchison JT,et al. The international association for the study of lung cancer lymph node map:A radiologic atlas and review[J]. Tubercul Resp Dis,2015,78(3):180 -189.
[5] 楊西.睡眠-運(yùn)動(dòng)干預(yù)對(duì)肺癌化療患者癌因性疲乏的作用[J]. 中國(guó)鄉(xiāng)村醫(yī)藥,2018,25(10): 58-59.
[6] 李玉華,陳立章.心理干預(yù)聯(lián)合健康教育對(duì)老年肺癌患者生存質(zhì)量和負(fù)性情緒的影響[J]. 中國(guó)老年學(xué)雜志,2015,35(19):5575-5576.
[7] Roberto HA,Kristopher PC,Pankaj P. Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations[J]. World Journal of Gastroenterology,2011,17(1):123-129.
[8] 中國(guó)抗癌協(xié)會(huì). 2010年中國(guó)肺癌臨床指南:中國(guó)肺癌臨床指南[M]. 北京:人民衛(wèi)生出版社,2010:110-116.
[9] 陳漫霞,羅輝,顏戊利,等.腫瘤化療患者睡眠質(zhì)量及其相關(guān)因素分析[J]. 現(xiàn)代預(yù)防醫(yī)學(xué),2014,41(8):1527-1529.
[10] 柳璐,王雙,許莉.腫瘤化療患者焦慮和抑郁情緒與應(yīng)對(duì)方式的關(guān)系研究[J]. 中國(guó)現(xiàn)代醫(yī)學(xué)雜志,2018,28(12):80-85.
[11] 路桃影,李艷,夏萍,等.匹茲堡睡眠質(zhì)量指數(shù)的信度及效度分析[J]. 重慶醫(yī)學(xué),2014,43(3):260-263.
[12] 丁金霞,王婷,王維利,等. 化療器癌癥患者癌因性疲乏與生命質(zhì)量的研究[J].中華疾病控制雜志,2015,19(5):462-465.
[13] Wanchai A,Armer JM,Stewart BR.Nonpharmacologic supportive strategies to promote quality of life in patients experiencing cancer-related fatigue: a systematic review[J].Clin J Oncol Nurs,2011,15(2):203-214.
[14] Shrividya I,Gavin T,Adam R. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany[J]. Lung? Cancer,2013, 3(8):3-6.
[15] Borges Marg. Exercise for the management of cancer-related fatigue in lung cancer systematic review[J]. European Journal of Cancer Care,2014,13(1):127-138.
[16] 姚曉軍,劉倫旭. 肺癌的流行病學(xué)及治療現(xiàn)狀[J]. 現(xiàn)代腫瘤醫(yī)學(xué),2014,22(8):1982-1986.
[17] 楊志彥,楚新霞. 化療前后肺癌患者生活質(zhì)量、焦慮抑郁情緒變化及生活質(zhì)量影響因素[J]. 中國(guó)醫(yī)藥導(dǎo)報(bào),2016,13(5):122-125.
[18] Hirai F,Seto T,Shimokawa M,et al. Split-dose cisplatin and vinorelbine as adjuvant chemoth erapy for completely resected non-small cell lung cancer[J]. Anticancer Res,2014,34(2):927-931.
[19] 李立平,段紅艷,劉衛(wèi)靜.個(gè)性化心理護(hù)理對(duì)晚期肺癌患者心理健康和生活質(zhì)量的影響[J]. 重慶醫(yī)學(xué),2015, 44(20):2876-2877.
[20] 吳艷,王海燕,陳霞. 肺癌化療患者應(yīng)用心理干預(yù)措施對(duì)其生活質(zhì)量及睡眠質(zhì)量的影響[J]. 中國(guó)健康心理學(xué)雜志,2019,27(4):559-562.
[21] 劉佳麗. 運(yùn)動(dòng)干預(yù)對(duì)乳腺癌化療患者癌因性疲乏和睡眠質(zhì)量的影響[J]. 世界睡眠醫(yī)學(xué)雜志,2018,5(7):792-794.
[22] 徐錦江,顧立學(xué),喬紅. 中西醫(yī)聯(lián)合運(yùn)動(dòng)療法對(duì)乳腺癌術(shù)后癌因性疲乏干預(yù)效果的研究[J]. 中國(guó)全科醫(yī)學(xué),2010, 13(28):3225-3226.
[23] Bixler E. Sleep and society:An epidemiological perspective[J]. Sleep Med,2009,10(Suppl 1):S3-S6.
[24] Johns SA,Brown LF,Beck Coon K,et al. Randomized controlled pilot trial of mindfulness based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer survivors[J]. Support Care Cancer,2016,24(10):4085-4096.
[25] Szentkirályi A,Madarász CZ,Novák M. Sleep disorders:Impact on daytime functioning and quality of Life[J]. Expert Rev Pharmacoecon Outcomes Res,2009,9(1):49-64.
[26] Black DS,O Reilly GA,Olmstead R,et al. Mindfulness meditation and improvement in sleep quality and daytime impair ment among older adults with sleep disturbances a randomized clinical trial[J]. JAMA Internal Medicine,2015,175(4):494-501.
(收稿日期:2019-07-23)